CD30 in Normal and Neoplastic Cells-Reference-Cited by-同舟云学术

CD30 in Normal and Neoplastic Cells

Published:1999-02 Issue:2 Volume:90 Page:157-164
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Chiarle Roberto,Podda Antonello,Prolla Gabriel,Gong Jerry,Thorbecke G.Jeanette,Inghirami Giorgio

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference101 articles.

1. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed–Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells;Stein;Blood,1985

2. Neoplastic Hematopathology;Stein,1992

3. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death;Smith;Cell,1994

4. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas;Gruss;Blood,1995

5. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease;Durkop;Cell,1992

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral T‐cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK‐negative;British Journal of Haematology;2024-04-12

2. Targeting CD 30 in Lymphoid Neoplasms;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

3. Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment;Genes;2024-01-22

4. A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study;Blood Research;2023-11-30

5. A Review of Hodgkin Lymphoma in the Era of Checkpoint Inhibitors;Cureus;2023-07-10